In a real-world comparative analysis: WW members achieved 72% greater average weight loss than a cohort receiving compounded GLP-1s through direct-to-consumer competitor (Hims & Hers) WW members achieved 30%+ greater average weight loss than select other competitors Members who combined medication with WW's GLP-1 Success Program saw 61.3% greater weight loss in month one vs
Weight Loss For individuals living with obesity, weight loss outcomes in early trials consistently exceeded expectations
Cintia Cercato declares having received consulting honoraria from Novo Nordisk, Eli Lilly, Merck, Brace Pharma and Eurofarma
L-Carnitine helps the body convert fat into energy, which benefits not just physical performance but also the vitality of organs that rely largely on effective energy usage, such as the heart and brain
Physical therapy evaluation can identify biomechanical issues and provide targeted interventions
The role of glia in the physiology and pharmacology of glucagon-like peptide-1: implications for obesity, diabetes, neurodegeneration and glaucoma